s.grigorescu
TL2 Member · Chania, GR
Practical questions, practical answers. Not interested in speculation without a source.
Joined 11 July 2025 · last posted 11d
73 posts, newest first. Showing up to 150.
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #108 · Compounds › Semaglutide · 17 Jul 2026 · 10 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #38 · Pharmacology › Receptor biology · 8 Jul 2026 · 20 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
-
Personal or family history of medullary thyroid carcinoma Replied, post #11 · Safety › Contraindications · 24 Jun 2026 · 3 likes Picking up post #10: that is the part I would want checked first. A history of pancreatitis appears in the cautions and the decision around it needs somebody who knows…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #29 · Sourcing › Independent verification · 19 Jun 2026 · 11 likes Post #28 is the version of this I will quote in future. One addition. The useful distinction on Janoshik is between what was measured and what was inferred from it.…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #19 · Access › International · 16 Jun 2026 · 2 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question. The strength of my opinion here…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #79 · Evidence › Preprints · 14 Jun 2026 · 22 likes On post #75 — agreed on the reasoning, with one qualification. A preprint that has been up for two years without appearing in a journal is telling you something, and it…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #83 · Sourcing › Vendor reports · 13 Jun 2026 · 30 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. Not the whole picture,…
-
Follow-up: Reading an interaction checker output critically Replied, post #4 · Practice › Interactions · 12 Jun 2026 · 6 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #23 · Analytics › HPLC & UHPLC · 11 Jun 2026 · 2 likes Retention time is only comparable within a laboratory on a given method. Quoting a retention time across two reports as evidence of identity is not a valid comparison.
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #2 · Clinical › Comorbidities · 11 Jun 2026 · 5 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Does a peptide degrade silently, with no visual change? Replied, post #42 · Practice › Storage & stability · 6 Jun 2026 · 3 likes That is clearer than the version I had in my head. Thank you.
-
Blind submission and why it changes minds — the long version Replied, post #107 · Sourcing › Independent verification · 30 May 2026 · 21 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Follow-up: Sleep quality changes during weight loss Replied, post #30 · Wellbeing › Sleep · 26 May 2026 · 0 likes The failure mode on Sleep quality changes during weight is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #100 · Devices › Syringes & needles · 8 May 2026 · 0 likes U-100 means the barrel is graduated for a solution containing one hundred units of insulin per millilitre. For anything that is not insulin, the units are simply…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #43 · Practice › Reconstitution · 8 May 2026 · 0 likes Building on post #41 rather than restating it. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible.…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #113 · Compounds › Tirzepatide · 7 May 2026 · 32 likes On 2.5 mg starting dose, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #3 · Compounds › Semaglutide · 27 Apr 2026 · 1 like Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Constipation management, with a dietitian's contribution Replied, post #56 · Practice › Side effects · 23 Apr 2026 · 32 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Second pass at: What pooling buys you and what it destroys Replied, post #35 · Evidence › Meta-analyses · 7 Apr 2026 · 0 likes Where I part company with post #31, and it is a narrow parting. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #25 · Sourcing › Red flags · 2 Apr 2026 · 0 likes An unexplained discrepancy that the supplier declined to address is a legitimate thing to record, stated as exactly that and nothing more. The honest answer is that it…
-
Prescription portability between countries Started this topic · Access › International · 1 Apr 2026 · 0 likes Prescription portability between countries — setting out what I have, and where I think it stops being reliable. Asking about prescription portability between countries…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #45 · Data & Tools › Datasets · 1 Apr 2026 · 5 likes Where the community side-effect dataset reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #26 · Clinical › Bloodwork · 29 Mar 2026 · 0 likes Lipid changes during substantial weight loss are expected and their trajectory is not always monotonic. A single mid-course panel can be misleading. Genuinely open to…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #93 · Research Methods › N-of-1 designs · 23 Mar 2026 · 5 likes On ABAB design the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #78 · Research Methods › N-of-1 designs · 18 Mar 2026 · 15 likes Posting my ABAB design numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #48 · Analytics › Impurities & related substances · 26 Feb 2026 · 4 likes Everything in post #46 holds. The case it does not cover is the one I have. The honest answer on impurities in solid-phase peptide synthesis is that it depends, and the…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #48 · Practice › Dosing & titration · 17 Feb 2026 · 9 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Five questions in one post gets you one answer — how to split them Replied, post #11 · Start Here › How to Ask · 11 Feb 2026 · 1 like Chromatography questions need the method before anything else: column, gradient, wavelength, injection volume. A purity figure with no method attached cannot be…
-
The most useful thing you learned here that was not the answer you came for Replied, post #18 · Lounge › Off topic · 2 Feb 2026 · 0 likes Off-topic but genuinely curious: how many people here came in through the analytics side rather than the practical side? The two groups seem to read completely…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #5 · Analytics › HPLC & UHPLC · 2 Feb 2026 · 19 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #116 · Analytics › COA interpretation · 22 Jan 2026 · 2 likes Building on post #113 rather than restating it. When a document puts the specification in the result column, it has told you the release criterion, not the measurement.…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #59 · Pharmacology › Pharmacokinetics · 14 Jan 2026 · 0 likes Narrowing post #57, because the general version has more than one answer. Terminal half-life estimated from a short sampling window underestimates the true value. That…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #3 · Evidence › Journal club · 28 Dec 2025 · 0 likes Where I have landed on semaglutide in MASH, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #25 · Practice › Side effects · 27 Dec 2025 · 0 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Heterogeneity as information rather than as a nuisance Replied, post #16 · Evidence › Meta-analyses · 5 Dec 2025 · 28 likes Where I have landed on heterogeneity, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
Documentation that appears only after payment Replied, post #92 · Sourcing › Red flags · 30 Nov 2025 · 13 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for.
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #28 · Data & Tools › Calculators · 22 Nov 2025 · 0 likes Dead volume is the input most calculators do not have, which is why their answer and the delivered dose differ slightly for detachable-needle configurations. On balance…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #4 · Meta › Site feedback · 18 Nov 2025 · 19 likes Adding a reference point for topic list. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #81 · Practice › Reconstitution · 13 Nov 2025 · 10 likes Helpful, and short, which on this subject is harder than long.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #49 · Practice › Interactions · 13 Nov 2025 · 3 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Prescription requirements and telehealth models Replied, post #6 · Sourcing › Regulatory · 8 Nov 2025 · 0 likes That is the distinction I keep failing to hold on to. Written down now.
-
Sleep tracking data and its considerable limitations Replied, post #127 · Wellbeing › Sleep · 29 Oct 2025 · 0 likes Sleep hygiene: basics (cool dark room, consistent sleep time, no screens before bed) matter more during energy deficit because stress and sleep need are higher.
-
Particulates in a reconstituted solution: identifying the likely source Replied, post #14 · Analytics › Impurities & related substances · 16 Oct 2025 · 8 likes Truncation products are substantially lower in mass and usually well separated chromatographically, which makes them the easiest class to see and the least likely to be…
-
Documentation that materially improves an appeal's chances Replied, post #27 · Access › Insurance & coverage · 13 Oct 2025 · 0 likes Second-hand on documentation, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
An orphaned page with no inbound links — the long version Replied, post #7 · Meta › Wiki maintenance · 8 Oct 2025 · 4 likes That is clearer than the version I had in my head. Thank you.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #66 · Practice › Side effects · 16 Sep 2025 · 1 like Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #32 · Compounds › Oral incretins · 9 Sep 2025 · 7 likes No notes. Posting so the count is not one.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #123 · Practice › Storage & stability · 26 Aug 2025 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
A request that was declined, and the reasoning — a second dataset Replied, post #74 · Documentation › Wiki requests · 13 Aug 2025 · 0 likes Post #70 describes the usual case. This is about the unusual one. Requests for a document covering something the evidence does not support get declined, and the decline…
-
Thyroid function tests during substantial weight change Replied, post #7 · Clinical › Bloodwork · 16 Jul 2025 · 18 likes Nobody has said the unglamorous part of thyroid function tests during substantial yet, so: most of the variation is explained by things that are boring to write about…
-
Counter-ion content and its effect on measured mass Replied, post #73 · Analytics › Mass spectrometry · 24 Jun 2025 · 0 likes No notes. Posting so the count is not one.
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #110 · Clinical › Comorbidities · 10 Jun 2025 · 6 likes A methods point on obstructive sleep apnoea rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in…
-
Follow-up: Tracking intake honestly when appetite is absent Started this topic · Nutrition & Training › Protein & intake · 31 May 2025 · 5 likes Tracking intake honestly when appetite is absent Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about Tracking…
-
Lean mass preservation: what the evidence supports Replied, post #13 · Outcomes › Body composition · 12 May 2025 · 0 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #12 · Evidence › Journal club · 20 Mar 2025 · 24 likes What I would want before treating STEP 4 as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing.
-
Validating a method you did not develop — does this still hold? Replied, post #126 · Analytics › Method validation · 17 Mar 2025 · 33 likes I had written a reply contradicting post #124 and deleted it. Here is what survived. A stability-indicating method is one demonstrated to resolve the analyte from its…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #64 · Sourcing › Vendor reports · 17 Mar 2025 · 0 likes The arithmetic in post #63 is right; the assumption feeding it is the part to check. Reports of ordinary results are more valuable than reports of remarkable ones,…
-
Charge states for a 4 kDa peptide, worked through Replied, post #113 · Analytics › Mass spectrometry · 15 Mar 2025 · 0 likes Building on post #110 rather than restating it. Two claims get bundled together under charge states and they need separating. The descriptive one — this is what was…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #42 · Sourcing › Regulatory · 1 Mar 2025 · 4 likes Post #41 answers the question as asked. The question underneath it is different. Taking pharmaceutical compounding rules seriously for a moment rather than deflecting:…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #2 · Practice › Interactions · 25 Feb 2025 · 20 likes If someone has run delayed gastric emptying and oral properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone…
-
Scheduled maintenance and what will be unavailable Replied, post #43 · Meta › Announcements · 14 Feb 2025 · 0 likes That reframing is the whole thing. The facts I already had.
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #9 · Sourcing › Vendor reports · 10 Feb 2025 · 11 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. A difference inside method repeatability is not a disagreement. Saying so in your own…
-
Oxidation pathways for methionine and tryptophan Replied, post #32 · Analytics › Impurities & related substances · 28 Dec 2024 · 1 like Adding the measurement that post #31 says would settle it. Adding what did not work for me on oxidation pathways for methionine, since the failures never get written up…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #16 · Evidence › Journal club · 18 Dec 2024 · 1 like If someone has run STEP 4 properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Fixed versus detachable needles: the trade-offs Replied, post #39 · Devices › Syringes & needles · 8 Dec 2024 · 1 like Post #35 put the caveat in the right place and I want to underline it. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #55 · Access › Insurance & coverage · 5 Dec 2024 · 0 likes Two people in this thread mean different things by Step therapy requirements and are disagreeing about the definition while believing they are disagreeing about the…
-
Coming back to: When to suspect the method rather than the sample Replied, post #28 · Analytics › Method validation · 4 Dec 2024 · 12 likes Post #25 is the version of this I will quote in future. One addition. Linearity across the working range is a routine demonstration and it constrains how far a result…
-
When to suspect the method rather than the sample Replied, post #41 · Analytics › Method validation · 24 Nov 2024 · 0 likes This follows post #39 rather than contradicting it. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as…
-
EMA product information as a primary source — does this still hold? Replied, post #2 · Regional › European Union · 14 Nov 2024 · 0 likes Taking the opening post at face value and following it one step further. Regional stock held inside the union removes a customs question entirely for intra-union…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #25 · Clinical › Comorbidities · 7 Oct 2024 · 4 likes Where I have landed on Type 2 diabetes, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #58 · Sourcing › Independent verification · 14 Sep 2024 · 21 likes Post #57 is right about the mechanism and I think understates the practical bit. Practical note on Splitting a vial: write down what you expect before you look. The…
-
Revisiting: US compounding rules and how they changed Replied, post #9 · Regional › North America · 7 Sep 2024 · 0 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do. A…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #6 · Practice › Dosing & titration · 25 May 2024 · 13 likes One caution on four-week escalation interval: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is…